Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07529899

A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Efficacy and Safety of Amnion Membrane Disc Allograft Versus Standard of Care in Participants With Moderate to Severe Dry Eye Disease

Status
Not Yet Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Cellution Biologics · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To evaluate the efficacy of Lyophilized Human Amnion Membrane Disc in reducing corneal epithelial damage as measured by the Lexitas Modified National Eye Institute (NEI) Grading Scale for Corneal Fluorescein Staining.

Detailed description

Dry Eye Disease (DED) is a chronic, progressive inflammatory multifactorial disease of the ocular surface characterized by a loss of homeostasis of the tear film. It is accompanied by ocular symptoms, in which tear film instability and hyperosmolarity, ocular surface inflammation and damage, and neurosensory abnormalities play etiological roles. DED creates a vicious cycle of ocular surface inflammation and damage. Beyond simple 'dryness', DED is recognized as a chronic, potentially progressive condition that can lead to significant visual impairment, corneal scarring, and a diminished quality of life (QoL) comparable to moderate-to-severe angina or dialysis. While standard therapies (lubricants, anti-inflammatory agents) manage symptoms, many patients suffer from refractory epithelial defects and keratitis. Human Amniotic Membrane (HAM) has been shown to possess anti-inflammatory, anti-scarring, and epithelial-promoting properties. The Human Amniotic Membrane (HAM) is the innermost layer of the placenta. It is uniquely suited for ocular surface reconstruction due to its complex biological scaffold.

Conditions

Interventions

TypeNameDescription
PROCEDUREStandard of Care (SOC)Standard of care is to perform eye cleansing with sterile saline, application of one drop of Ofloxacin prophylactically to eye, application of topical anesthetic, application of bandage lens to eye, application of drops of saline as needed to ensure hydration, taping eye partially shut and continuation of preservative free topical lubricating drops.
OTHERLyophilized Amnion Membrane Disc AllograftLyophilized Amnion Membrane Disc Allograft derived from donated human tissues.

Timeline

Start date
2026-07-01
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2026-04-14
Last updated
2026-04-14

Source: ClinicalTrials.gov record NCT07529899. Inclusion in this directory is not an endorsement.